119 related articles for article (PubMed ID: 37451557)
1. Novel D-modified heterocyclic androstane derivatives as potential anticancer agents: Synthesis, characterization, in vitro and in silico studies.
Šestić TL; Ajduković JJ; Bekić SS; Ćelić AS; Stojanović ST; Najman SJ; Marinović MA; Petri ET; Škorić DĐ; Savić MP
J Steroid Biochem Mol Biol; 2023 Oct; 233():106362. PubMed ID: 37451557
[TBL] [Abstract][Full Text] [Related]
2. New A-homo lactam D-homo lactone androstane derivative: Synthesis and evaluation of cytotoxic and anti-inflammatory activities in vitro.
Savić MP; Škorić DĐ; Kuzminac IZ; Jakimov DS; Kojić VV; Rárová L; Strnad M; Djurendić EA
Steroids; 2020 May; 157():108596. PubMed ID: 32068078
[TBL] [Abstract][Full Text] [Related]
3. Development of new steroid-based hydrazide and (thio)semicarbazone compounds with anticancer properties.
Janković ÐD; Šestić TL; Bekić SS; Savić MP; Ćelić AS; Scholda J; Kopp F; Marinović MA; Petri ET; Ajduković JJ
J Steroid Biochem Mol Biol; 2024 Sep; 242():106545. PubMed ID: 38762058
[TBL] [Abstract][Full Text] [Related]
4. 17(E)-picolinylidene androstane derivatives as potential inhibitors of prostate cancer cell growth: antiproliferative activity and molecular docking studies.
Ajduković JJ; Djurendić EA; Petri ET; Klisurić OR; Celić AS; Sakač MN; Jakimov DS; Gaši KM
Bioorg Med Chem; 2013 Dec; 21(23):7257-66. PubMed ID: 24148837
[TBL] [Abstract][Full Text] [Related]
5. Synthesis,
Stevanović MZ; Bekić SS; Petri ET; Ćelić AS; Jakimov DS; Sakač MN; Kuzminac IZ
Future Med Chem; 2024; 16(11):1127-1145. PubMed ID: 38629440
[TBL] [Abstract][Full Text] [Related]
6. Androstane derivatives induce apoptotic death in MDA-MB-231 breast cancer cells.
Jakimov DS; Kojić VV; Aleksić LD; Bogdanović GM; Ajduković JJ; Djurendić EA; Penov Gaši KM; Sakač MN; Jovanović-Šanta SS
Bioorg Med Chem; 2015 Nov; 23(22):7189-98. PubMed ID: 26494582
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticancer potential of novel 5,6-oxygenated and/or halogenated steroidal d-homo lactones.
Kuzminac IZ; Jakimov DS; Bekić SS; Ćelić AS; Marinović MA; Savić MP; Raičević VN; Kojić VV; Sakač MN
Bioorg Med Chem; 2021 Jan; 30():115935. PubMed ID: 33340938
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative and antimetastatic characterization of an exo-heterocyclic androstane derivative against human breast cancer cell lines.
Kulmány ÁE; Frank É; Kovács D; Kirisits K; Krupitza G; Neuperger P; Alföldi R; Puskás LG; Szebeni GJ; Zupkó I
Biomed Pharmacother; 2021 Aug; 140():111728. PubMed ID: 34020244
[TBL] [Abstract][Full Text] [Related]
9. In silico ADMET analysis of the A-, B- and D-modified androstane derivatives with potential anticancer effects.
Šestić TL; Ajduković JJ; Marinović MA; Petri ET; Savić MP
Steroids; 2023 Jan; 189():109147. PubMed ID: 36410412
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of A-ring fused pyridine d-modified androstane derivatives for antiproliferative and aldo-keto reductase 1C3 inhibitory activity.
Savić MP; Ajduković JJ; Plavša JJ; Bekić SS; Ćelić AS; Klisurić OR; Jakimov DS; Petri ET; Djurendić EA
Medchemcomm; 2018 Jun; 9(6):969-981. PubMed ID: 30108986
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structural analysis and antitumor activity of novel 17α-picolyl and 17(E)-picolinylidene A-modified androstane derivatives.
Ajduković JJ; Penov Gaši KM; Jakimov DS; Klisurić OR; Jovanović-Šanta SS; Sakač MN; Aleksić LD; Djurendić EA
Bioorg Med Chem; 2015 Apr; 23(7):1557-68. PubMed ID: 25737400
[TBL] [Abstract][Full Text] [Related]
12. Preselection of A- and B- modified d-homo lactone and d-seco androstane derivatives as potent compounds with antiproliferative activity against breast and prostate cancer cells - QSAR approach and molecular docking analysis.
Kovačević SZ; Podunavac-Kuzmanović SO; Jevrić LR; Vukić VR; Savić MP; Djurendić EA
Eur J Pharm Sci; 2016 Oct; 93():107-13. PubMed ID: 27503457
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and biological evaluation of some 16E-arylidene androstane derivatives as potential anticancer agents.
Guo H; Wu H; Yang J; Xiao Y; Altenbach HJ; Qiu G; Hu H; Wu Z; He X; Zhou D; Hu X
Steroids; 2011 Jun; 76(7):709-23. PubMed ID: 21473874
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Novel Pyridine Bearing Biologically Active Imidiazolyl, Pyrazolyl, Oxa/thiadiazolyl and Urea Derivatives as Promising Anticancer Agents.
Hafez HN; El-Gazzar ABA
Curr Org Synth; 2020; 17(1):55-64. PubMed ID: 32103718
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and biological evaluation of some 16β-azolyl-3β-amino-5α-androstane derivatives as potential anticancer agents.
Guo H; Zhang G; Zhang T; He X; Wu Z; Xiao Y; Pan Y; Qiu G; Liu P; Hu X
Eur J Med Chem; 2011 Sep; 46(9):3662-74. PubMed ID: 21641694
[TBL] [Abstract][Full Text] [Related]
16. Modified bile acids and androstanes-Novel promising inhibitors of human cytochrome P450 17A1.
Dzichenka Y; Shapira M; Yantsevich A; Cherkesova T; Grbović L; Savić M; Usanov S; Jovanović-Šanta S
J Steroid Biochem Mol Biol; 2021 Jan; 205():105777. PubMed ID: 33157220
[TBL] [Abstract][Full Text] [Related]
17. Anti-cancer activity, and molecular docking of novel hybrid heterocyclic steroids revealed promising anti-hepatocellular carcinoma agent: Implication of cyclin dependent kinase-2 pathway.
Tantawy MA; Shalby AB; Barnawi IO; Kattan SW; Abd-Rabou AA; Elmegeed GA
Steroids; 2023 May; 193():109187. PubMed ID: 36736802
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities.
A A Fadaly W; A M M Elshaier Y; T M Nemr M; R A Abdellatif K
Bioorg Chem; 2023 May; 134():106428. PubMed ID: 36893546
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity,
Tantawy MA; Shaheen S; Kattan SW; Alelwani W; Barnawi IO; Elmgeed GA; Nafie MS
J Biomol Struct Dyn; 2022 Jul; 40(10):4352-4365. PubMed ID: 33300466
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors.
Acar Çevik U; Celik I; Işık A; Ahmad I; Patel H; Özkay Y; Kaplancıklı ZA
J Biomol Struct Dyn; 2023 Mar; 41(5):1944-1958. PubMed ID: 35037830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
